Granules India gets USFDA nod for naproxen sodium tablet

Granules India has received approval from the US Food and Drug Administration (FDA) for its naproxen sodium tablet, the generic version of Bayer AG’s Aleve pain relieving medicine,

The company is producer of active pharmaceutical ingredients (API's) and pharmaceutical formulation intermediates (PFIs) with complete vertical integration. They expertise in manufacturing PFIs which are Directly Compressible Granules has helped customers to move to the next level of outsourcing in the pharmaceutical industry.